This story was first published in digitalhealth.net
Accelerated approval given for COVID-19 vaccine trial
The Medicines and Healthcare products Regulatory Agency (MHRA) approved the COVID-19 Oxford Vaccine Trial request in just over one working week, following its pledge to prioritise clinical trial applications submitted for COVID-19.
The application was made on 18 March, and on 26 March the MHRA gave the COVID-19 Oxford Vaccine Trial the green light.
Scientists in Oxford started working on designing a vaccine early in January 2020, and have now identified one to start the first clinical testing phase. If the vaccine is proven to be safe and effective in this and larger trials, it could protect people and help save lives.
The project is supported by a joint funding schemebetween the UK Research and Innovation (UKRI) and National Institute for Health Research (NIHR).
Dr June Raine, Chief Executive for the MHRA, said: "The dedicated scientific advice and rapid approval of this important clinical trial demonstrate our commitment to working together to find a vaccine for this pandemic.
"We support the development and expedite authorisation of clinical trials for COVID-19 treatments, whilst maintaining our high regulatory standards to ensure the safety of people involved in the trials.
"Protecting health and saving lives is at the forefront of our work, and we are committed to enabling the development of safe and effective vaccines and treatments for this virus."
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
